(Reuters) -Genetic testing firm 23andMe said on Monday it is reducing about 40%, or 200 employees, from its workforce and discontinuing further development of all its therapies as part of a restructuring program. “We are taking these difficult but necessary actions as we restructure 23andMe and focus on the long-term success of our core consumer…
BP shares rise as FT reports more rivals looking at possible takeover Source link
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, will adversely affect certain features and functions. The technical storage or access is strictly…
Source: Financial Times Source link
STOCK TIPS FORÂ MAY 06Â 2025Â STOCK (FUTURE / CASH / OPTION ) NIFTY (FUTURE / OPTION) BANK NIFTY (FUTURE / OPTION) FUTURE STOCK TIPS:Â XXXÂ Â Â Â Â Â (MAY. FUT. LOT.) BUY ABOVE XX TGT XXX S/L XX AND SELL BELOW XX TGT XXX S/L XX XXXÂ Â Â Â Â Â (MAY. FUT….
BTC/USD – In a Third Wave Source link